Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SpotLight-THC for Cannabis Impairment Detection
NCT05276232Phase 1Unknown
- Sponsor
- ISBRG Corp.
- Start
- Mar 2022
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by ISBRG Corp. Primary endpoint: Change in Acute Subjective Response to Cannabis Score. Status: unknown.
Beyond the preview
Go deeper on NCT05276232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276232.